First Year Curriculum About the Program Seminars & Schedule Student Life Application Financial Information
Genetics & Development Structural Biology Cancer Biology
Marine Biomedicine & Environmental Science Cardiovascular Biology Cell Regulation
MCBP Home Contact Us College of Graduate Studies MUSC Home
Cancer Biology
Dennis K. Watson, Ph.D. - Division Director

Areas of Research Interest

  • Apoptosis
  • Angiogenesis
  • Migration and Invasion
  • Metastasis
  • Tumor Microenvironment
  • Molecular Profiling
  • Immunotherapy
  • Gene Therapy
  • Small Molecule Intervention

The Cancer Biology Program, an interdisciplinary program leading to a Ph.D degree, was established in 2001 to provide students with training in diverse areas of cancer biology research. Cancer is a multi-step disease resulting from a series of genetic and epigenetic changes that abrogate normal cellular controls. The goal of the program is to develop within each student the approach to scientific thought founded upon basic molecular biology relevant to cancer needed for original research as an independent investigator in cancer biology.

The Cancer Biology Program is composed of MUSC faculty whose interests include basic studies in molecular biology, biochemistry, genetics, cell biology and immunology to translational research focused on problems of immediate clinical applicability. The Cancer Biology curriculum provides an overview of cancer biology and allows students the opportunity to pursue research under faculty mentors who conduct research relevant to understanding the molecular or cellular basis of any aspect of the cause, characteristics and treatment of cancer. Thus, the Cancer Biology Program provides research opportunities in many areas of Cancer Biology including Functional Genetics, Molecular Biology of Cancer, Experimental Therapeutics and Cancer Immunology. Students are encouraged to use the resources and expertise of several laboratories during the development of their cancer related dissertation projects, providing an enhanced experience that increases the expertise and competitiveness of our graduates. Successful students complete a publishable research project under a faculty mentor and present the research as a thesis.

Cancer Biology Course Descriptions

MCBP-725D Topics in Cancer Research
Selected topics will be presented by individual students in Journal Club style. Students will present selected papers 2 times during the course and will be active discussants when other students are presenting.
Recent topics previously covered include:

Tumor metastasis Suppressor Genes
Chemokines
Oxidative stress and cancer
Cancer progenitor cells & drug resistance
miRNA
Senescense
VEGF, angiogenesis and lymphangiogenesis
Inflammation and cancer

Bone marrow derived cells
Tumor microenvironmentRTK-targeted therapies
Angiogenesis
Immune Evasion and Tumor Immunology
MAK Kinases
Apoptosis and mitochondrial fission/fusion
Transgenic and Knockout Analysis

Prerequisites: None.
Credits: 2 (Pass/Fail)
Rosenzweig and Watson

PCOL-725 Advanced topics in Cell Signaling
The vast majority of human diseases involve defects in cellular communication and therapeutic intervention often targets molecules involved in cell signaling. This course will dissect signaling cascades and their alterations in disease states addressing cutting edge issues. The course will be offered each Fall with the theme rotating among three broad topics: Cell Signaling in the Cardiovascular System, Cell Signaling in Cancer, Cell Signaling in the Nervous System. Specific diseases under these broader categories will be selected by faculty or students and then each disease will be dissected by one of the course participants (oral/written) to understand how signaling events are affected, how signaling dysfunction contributes to the onset or progression of the disease and how signaling events might be targeted in a therapeutic attack on the disease. The course is intended for advanced graduate and postgraduate students and will be coordinated with the Cell-Signaling Seminar Series (organized through the Department of Pharmacology) held each Fall, thus allowing seminar speakers to participate in the course.
Prerequisites: None.
Credits: 3
Kurtz

BMB-605B Mechanisms of Cancer Pathogenesis
Prerequisties: None
Credits: 3
Hannun & Ogretmen

MBIM 716 Development of Molecular Cancer Therapies: From Bench to Bedside
This course is organized into 7 sections (1) Introduction to cancer causation, initiation, molecular basis, and genetics; (2) Cancer molecular pathology and diagnosis; (3) Cancer imaging; (4) Immunology of cancer; (5) Drug therapy; (6) Cancer epidemiology, prevention and control; (7) Translational reserch
Credits: 2
Tew and Norris


Cancer Biology Faculty

Alexander Awgulewitsch, Ph.D.
Associate Professor
Rheumatology/Immunology
Transgenic mouse models for skin cancer and the role of Hox genes in skin development & cancer

Craig Beeson, Ph.D.
Associate Professor
Department of Pharmaceutical Sciences
Development of topoisomerase I inhibitors

Narayan R. Bhat, Ph.D.
Professor
Department of Neurology
Growth factor signaling and gliomagenesis

Robert J. Boackle, Ph.D.
Professor of Immunology
Professor and Director of Oral Biology, Department of Stomatology
Mucosal immunity, inflammation, mucosal defense against HIV, complement chemistry, cancer immunotherapy

Maria G. Buse, M.D.
Professor, Division of Endocrinology
Cell regulation and hormones in relation to cancer

David J. Cole, M.D.
Professor
Department of Surgery
Mechanisms of T-cell recognition of tumor antigens to translate into ongoing clinical cancer vaccine/gene therapy trials

Christopher J. Drake, Ph.D.
Professor
Department of Cell Biology & Anatomy
The control and regulation of neovascular processes (angiogenesis & vasculogenesis) in tumor growthand metastasis

Weiman Fan, M.D., M.P.H.
Professor
Department of Pathology and Laboratory Medicine
Molecular Oncology, experimental therapeutics, and tumor growth regulation

Sebastiano Gattoni-Celli, M.D.
Professor
Radiation Oncology
Immunotherapy of cancer

Yusuf A. Hannun, M.D.
Ralph F. Hirschmann Professor and Chairman
Biochemistry and Molecular Biology
Tumor promotion/apoptosis, cancer therapeutics

Stanley R. Hoffman, Ph.D.
Professor
Rheumatology/Immunology
Function of specific ECM proteins and MMP's in metastasis & tumaor angiogenesis

Tien Hsu, Ph.D.
Professor
Hollings Cancer Center
Drosophila model systems for studying cancer-related gene functions

Karl J. Karnaky, Ph.D.
Associate Professor
Cell Biology & Anatomy
Role of membrane transporters, MRP1 and MRP2, in regulating exposure of human breast epithelial cells to xenobiotic and endogenous molecules

Michael Kern, Ph.D.
Associate Professor
Cell Biology & Anatomy
Target genes of homeobox transcription factors in cancer: microarrays and beyond.

Steven W. Kubalak, Ph.D.
Associate Professor
Cell Biology & Anatomy
Transforming growth factor-beta regulation of apoptosis

Dhandapani Kuppuswamy, Ph.D.
Associate Professor
Department of Medicine, Division of Cardiology
Use terminally differentiated cardiac cells to identify factors that could negatively influence cancer cell growth

Runzhao Li, M.D., M.Sc.
Assistant Professor
Department of Medicine
Center for Molecular & Structural Biology
Modulation of Ets transcription factors in tumor angiogenesis and apoptosis protein-protein interaction and the signals in transcriptional control of Ets target genes. Gene therapy, application of tumor suppressor genes and oncogenes for developing new anti-neoplastic targets.

 

 

 












JoEllyn M. McMillan
Assistant Professor
Cell Biology and Anatomy
Mechanisms of hepatocarcinogenesis

Michael Mitas, M.D.
Assistant Professor
Department of Surgery
Breast cancr diagnostics and detection of associated genes

Robin C. Muise-Helmericks, Ph.D.
Assistant Professor
Cell Biology and Anatomy
Hollings Cancer Institute
Role of the Ets family of transcription factors in angiogenesis and lymphoid development

James S. Norris, Ph.D.
Professor and Chairman
Microbiology & Immunology
Apoptosis & apoptosis signaling, bystander effect, ceramide, combined chemotherapy-gene therapy, and apoptosis inducing gene FasL, TRAIL, & BAX

Lina M. Obeid, M.D.
Professor
Medicine
Role of sphingolipids in tumor angiogenesis

Makio Ogawa, M.D., Ph.D.
Professor
Department of Medicine
Division of Experimental Hematology
Differentiation and proliferation of hemopoietic stem cells

Besim Ogretmen, Ph.D.
Professor
Department of Biochemistry
Regulation of telomerase and roles of sphingolipids in cancer chemotherapy

Swapan K. Ray, Ph.D.
Associate Professor
Department of Neurology
involvement of calpain, a Ca2+-dependent cysteine protease, in the molecular mechanisms of cell death in disorders and diseases of the central nervous system

Steven A. Rosenzweig, Ph.D.
Professor
Cell and Molecular Pharmacology
Tumorigenesis, angiogenesis, hypoxia-inducible factor, IGF-binding proteins, receptor tyrosine kinases, and protein:protein interactions

Clifford W. Schweinfest, Ph.D.
Professor
Department of Experimental Oncology
The role of the growth suppressor gene, DRA, in colorectal neoplasia and the role of mismatch repair genes in prostate cancer

Eleanor K. Spicer, Ph.D.
Professor
Biochemistry and Molecular Biology
Post-transcriptional regulation of human bcl-2 expression

Demetri D. Spyropoulos, Ph.D.
Associate Professor
Department of Medicine
Lymphoid, breast, bladder, prostate, & colon cancer

Stephen Tomlinson, Ph.D.
Professor
Microbiology & Immunology
Role of complement & complement inhibitors in tumorigenesis and immune response to cancer

Bryan Toole , Ph.D.
Professor
MCBP
Hyaluronan and emmprin in cell survival signaling pathways, multidrug resistance, epithelial-mesenchymal transition, angiogenesis and invasiveness in cancer

Maria Trojanowska, Ph.D.
Professor
Rheumatology/Immunology
The role of stromal cells in tumor growth and progression

Christina Voelkel-Johnson, Ph.D.
Assistant Professor
Microbiology and Immunology
Apoptotic signaling and resistance mechanisms, metastasis, cancer therapy

Thomas Walle, Ph.D.
Professor
Professor of Cell and Molecular Pharmacology
Carcinogenesis: prevention and toxicology

Michael J. Wargovich, Ph.D.
Professor
Cell and Molecular Pharmacology
Cell and Molecular mechanisms of action

Dennis K. Watson, Ph.D.
Professor
Laboratory of Cancer Genomics
Pathology & Laboratory Medicine
Mechanisms of cancer initiation, progression, and metastasis

M. Rita I. Young, Ph.D.
Professor of Medicine
Department of Hematology Oncology
Cancer motility, Angiogenesis, Imunotherapy



First Year Curriculum*About the Program*Seminars*Student Life*Applications*Financial Information
MCBP Home*Contact Us*College of Graduate Studies*MUSC Home

Genetics & Development*Structural Biology*Cancer Biology
Marine Biomedicine*Cardiovascular Biology*Cell Regulation